Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: A Discrete Choice Experiment Among Patients in Five Non-Western Countries
Patients with IBD from non-Western countries prioritised advanced treatment attributes such as efficacy outcomes and RoAs, although treatment preferences varied between patients with CD and UC. Shared decision-making between patients and physicians regarding advanced therapy choice and timing should occur throughout the treatment journey.
Authors
- Nahla Azzam (ORCID: https://orcid.org/0000-0002-2097-289X)
- Elenore Judy B. Uy (ORCID: https://orcid.org/0000-0003-1062-8638)
- Olga Fadeeva
- Julie Laurent (ORCID: https://orcid.org/0000-0002-1705-7631)
- Marjorie Argollo (ORCID: https://orcid.org/0000-0001-9867-8861)
- Yoon K An
- Chia-Jung Kuo
Institutions
- King Saud University (SA)
- Chang Gung Memorial Hospital (TW)
- Takeda (Singapore) (SG)
- Hospital Privado (AR)
- Mater Adult Hospital (AU)
- Takeda (Japan) (JP)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1007/s12325-025-03249-w
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Takeda Pharmaceuticals International